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Abstract
The aim of the present study was to investigate the hypocholesterolemic effect and potential of tyramine derivatives from Lycii Cortex Radicis
(LCR), the root bark of lycium (Lycium chenese Miller) in reducing lipid peroxidation. The activities of enzymes, hepatic 3-hydroxy 3-methylglutaryl
(HMG) CoA reductase and acyl-CoA:cholesterol acyltransferase (ACAT) and LDL oxidation were measured in vitro and animal experiments were
also performed by feeding LCR extracts to rats. The test compounds employed for in vitro study were trans-N-p-coumaroyltyramine (CT) and 
trans-N-feruloyltyramine (FT), LCR components, N-(p-coumaroyl)serotonin (CS) and N-feruloylserotonin (FS) from safflower seeds, ferulic acid (FA)
and 10-gingerol. It was observed that FT and FS at the concentration of 1.2 mg/mL inhibited liver microsomal HMG CoA reductase activity by
~ 40%, but no inhibition of activity was seen in the cases of CT, CS, FA and 10-gingerol. Whereas, ACAT activity was inhibited ~ 50% by FT 
and CT, 34-43% by FS and CS and ~80% by 10-gingerol at the concentration of 1 mg/mL. A significant delay in LDL oxidation was induced 
by CT, FT, and 10-gingerol. For the animal experiment, five groups of Sprague-Dawley male rats were fed high fat diets containing no test material
(HF-control), 1 and 2% of LCR ethanol extract (LCR1 and LCR2), and 1% of extracts from safflower seed (Saf) and ginger (Gin). The results
indicated that total cholesterol level was significantly lower in Saf, LCR2 and Gin groups, and HDL cholesterol level was lower only in Gin group
when compared with HF-control group; while there was no difference in the serum triglyceride levels among the five experimental groups. The
level of liver cholesterol was significantly lower in LCR1 and LCR2 groups than HF-control. Serum levels of TBARS were significantly lower 
only in LCR2 group when compared with HF-control group. From the observed results, we concluded that LCR can be utilized as a hypocholesterolemic
ingredient in combination with ginger, especially for functional foods.
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Introduction6)
Atherosclerosis is a multi-factorial disease. Hypercholes-
terolemia and oxidation of plasma low density lipoprotein (LDL) 
are known to be the main factors for causing atherogenesis. Sixty 
to seventy percent of the body cholesterol has been known to 
be of endogenous origin. The most important step in endogenous 
cholesterol synthesis is the reaction mediated by a rate-limiting 
enzyme, 3-hydroxy 3-methylglutaryl (HMG) CoA reductase. A 
number of commercially available, serum cholesterol lowering 
agents had been developed on the basis of inhibition of HMG 
CoA reductase activity [1-4]. Since the development of such 
agents, many other derivatives have been synthesized and 
prescribed to hyperlipidemic patients. As most of the afore-
mentioned drugs are imported from foreign pharmaceutical 
companies and are therefore expensive, they cause significant 
economic burden on individuals as well as on the whole nation. 
In addition, many hyperlipidemic subjects are reluctant to use 
pills, and practitioners look for some other options rather than 
medicines to offer to the public, who just need an advice. Several 
vegetable food substances, like tocotrienol in barley [5], various 
organosulfur compounds in garlic [6], bioflavonoids [7,8], and 
extracts of sorghum and prosmillet [9] have been reported to 
inhibit HMG CoA reductase activity. Furthermore, HMG CoA 
reductase inhibitory activity has also been identified in 
polyphenols from safflower seed [10], soybean peptide [11], and 
several plants [12,13]. Many patients who received HMG CoA 
reductase inhibitors, however, did not achieve the desired 
cardiovascular benefits. Accordingly, other mechanisms via 
which cholesterol metabolism is regulated have drawn great 
attention, amongst which acyl-CoA:cholesterol acyltransferase 
(ACAT) activity has been known to be a typical one. ACAT, 
a cholesterol-esterifying enzyme in tissues plays key roles in 
intracellular cholesterol storage, lipoprotein assembly in the liver, 
and the development of fatty streaks in arteries. Accumulation 
of cholesteryl esters within macrophages constitutes the hallmark 
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Fig. 1. Structures of serotonin derivatives (a,b), ferulic acid (c), tyramine derivatives (d,e), simvastatin (f), gingerol (g), and pactimibe (h). a, N-(p-coumaroyl)serotonin 
(CS);  b,  N-feruloylserotonin  (FS);  c,  ferulic  acid;  d,  trans-N-p-coumaroyltyramine  (CT);  e,  trans-N-feruloyltyramine  (FT);  f,  simvastatin;  g,  gingerol;  h,  pactimbe. 
of foam cells during atherogenesis. Therefore, considerable 
interest has been emerged in developing ACAT inhibitors. In 
Korea, several natural substances [14], flavonoids isolated from 
the roots of Glycine max (L.) Merr. [15], and dammarane 
triterpenes from Rhus chinensis [16] have been identified as 
materials, which inhibit ACAT activity. Internationally, pactimibe 
sulfate (CS-505;[7-(2,2-dimethylpropanamido)-4,6-dimethyl-1-octy-
lindolin-5-yl]acetic acid), a well characterized compound which 
had been developed as a synthetic ACAT inhibitor, exhibited 
positive results in studies where ACAT activity inhibition and 
anti-atherosclerotic potency of macrophages were investigated by 
employing animal models [17-19]. Although no effect was 
observed in human study unlike in animal ones [20], the effect 
of ACAT inhibitor on prevention of hyperlipidemia still remains 
to be investigated. As transformation of macrophages into foam 
cells due to serum LDL oxidation and vascular plaque formation 
accelerates atherosclerosis [21], it is very important to identify 
materials suppressing LDL oxidation. Antioxidants like, vitamins 
E and C [22], soybean isoflavone [23], and vegetable polyphenols 
obtained from safflower seeds [10] were reported to be major 
materials inhibiting LDL oxidation. In addition, various 
substances are routinely being explored as inhibitors of LDL 
oxidation.
This study was conducted to investigate the anti-hyper-
lipidemic effect of Lycii Cortex Radicis (LCR), the dried root 
bark of lycium, which is cultivated in Korea. Lycium (Lycium 
chenese Miller), which belongs to the solanacea family, has been 
extensively used in traditional Chinese herbal medicine as an 
antipyretic agent and to treat pneumonia, night-sweats, cough, 
hematemesis, inflammation, and diabetic mellitus. Hypoglycemic 
effect of lycium was confirmed in alloxan-induced diabetic mice, 
and a decrease in blood cholesterol and triglyceride level was 
also observed [24]. LCR has been reported to inhibit skin damage 
caused by UV [25] and hepatic damage caused by CCl4 [26], 
and proposed to possess antioxidant activity; but no reports are 
available on the substances responsible for the antioxidant 
potential. However, a group of phenolic amide were isolated from 
the LCR and shown to have anti-fungal effects [27]. Amongst 
them are trans-N-p-coumaroyltyramine (CT) and trans-N- 
feruloyltyramine (FT). As can be seen in Fig. 1, their structures 
are similar to the structures of N-(p-coumaroyl)serotonin (CS) 
and  N-feruloylserotonin (FS), the serotonin derivatives in 
safflower seeds. As HMG CoA reductase activity has been 
reported to be inhibited by the serotonin derivatives [10], it is 
also necessary to examine the effect of the LCR phenolic amides. 
Hence, in our present study, the inhibitory effects of CT, and 
FT, the LCR phenolic amides on HMG CoA reductase activity 
were investigated. In addition, the inhibitory effects of CT and 
FT on ACAT activity and LDL oxidation were also examined. 
Furthermore, the effect of gingerols, important components of 
ginger, was also investigated to explore its utilization in 
association with LCR. Based on the results of the in vitro studies, 
an  in vivo study was conducted to investigate the effects of 
high fat diets with ethanol extracts of LCR, safflower seed, and 
ginger on serum and liver lipid levels and lipid peroxidation in 
rats.414 Hypocholesterolemic effect of  Lycii Cortex Radicis
Materials and Methods 
Materials 
The enzymes, NADPH, HMG CoA, mevalonic acid, and 
oleoyl CoA used in HMG CoA reductase and ACAT assay were 
purchased from Sigma-Aldrich (St. Louis, USA), and HMG CoA 
14C and Oleoyl-CoA 
14C were purchased from PerkinElmer 
(NEN) (Boston, USA). Ferulic acid, coumaric acid and 10- 
gingerol were purchased from Sigma-Aldrich (St. Louis, USA), 
and simvastatin was from MSD Korea (Zokor). Mineral mix, 
vitamin mix casein, cornstarch, and cellulose were purchased 
from Central Lab Animal Inc. (Seoul, Korea). Sucrose, soybean 
oil and lard were purchased from a local market. All other 
chemicals used in this study were of analytical grade.
Preparation of test compounds and organic extracts 
The serotonin derivatives, CS and FS were isolated from 
safflower seeds by following a method developed by Kang et 
al. [28]. The phenolic amides CT and FT, were prepared via 
a method developed by Rajan et al. [29] instead of carrying out 
isolation from LCR. The two tyramine derivatives were synthe-
sized by using either coumaric acid or ferulic acid and tyramine 
hydrochloride as reactants and N-(3-dimethylaminopropyl)-N- 
ethylcarbodiimide hydrochloride as a coupling reagent. The 
purification of the derivatives was carried out by silica gel 
column chromatography (CHCl3-MeOH = 8:1, v/v), followed by 
re-crystallization. The synthetic tyramines were confirmed to be 
identical with the ones purified from LCR by HPLC analysis 
coupled with UV detection at 310 nm [30]. The synthetic 
tyramines were used in in vitro experiments, because it was more 
convenient to prepare small amounts in pure forms based on 
requirement of the experiment. For animal experiments, 80% 
ethanol extracts of defatted safflower seed containing CS and 
FS, LCR containing CT and FT, and ginger containing gingerols 
were used as test materials. The extracts were prepared from 
dry powder of safflower seed, LCR and ginger. Hundred grams 
of individual powder was extracted twice with 1 L of 80% 
aqueous EtOH for 2 hr, filtered and evaporated under reduced 
pressure. Each extract was variously diluted and passed through 
Sep-Pak C18 cartridges (Waters, USA) and injected into HPLC 
[Waters 2695 Alliance HPLC system coupled with Water 2998 
photodiode array detector (Waters, Milford, MA, USA)]. Based 
on the calibration curves of standard compounds, CS, FS, and 
gingerol were quantified at 280 nm by using a linear gradient 
elution from 0.05% H3PO4 to 100% MeOH. Similarly, CT and 
FT were quantified at 310 nm by using another linear gradient 
from 0.05% trifluoroacetic acid to 100% acetonitrile [30]. 
Contents of each of the compounds in the extracts were identified 
as, CS, 3.4 wt%, FS, 5.0 wt%, CT, 0.39 wt%, FT, 0.29 wt%, 
and gingerols, 6.3 wt%.
HMG CoA reductase and ACAT activity assay 
Male Sprague-Dawley rats weighing 150 ± 10 g were fed with 
a commercial non-purified diet (to which 2% cholestyramine was 
added) for 10 days. After the completion of feeding, the rats 
were anesthetized with ether at 8 pm, and the microsome was 
isolated from liver tissue and used as a source of HMG CoA 
reductase and ACAT [31]. HMG CoA reductase assay by using 
14-C HMG CoA was carried out as described previously [10]. 
Typically, 2 μl of test materials (5-20 mg/mL DMSO) were added 
to a total 33 μl of the enzyme reaction mixture. ACAT assay 
by using [14-C]oleoyl-CoA was carried out according to the 
method of Lee and Choi [12]. About 10 μl of test materials (5-20 
mg/mL DMSO) were added to a total 200 μl of ACAT reaction 
mixture.
LDL oxidation 
LDL was prepared from human serum and LDL oxidation was 
induced by CuSO4,  and measured according to the method of 
Hirano et al. [32]. LDL oxidation was initiated by the addition 
of 5 μM Cu2SO4 at a final concentration in 0.8 ml of LDL 
solution (~100 μg protein/mL PBS, pH 7.4). To examine the 
anti-oxidative effects of the test compounds, 4 μl of the test 
materials were added to the LDL solution such that the final 
concentration was 2.5 μg/mL. The kinetics of the LDL oxidation 
were determined spectrophotometrically by monitoring the 
change in conjugate diene formation at 234 nm by Thermo Model 
9423AQA2200E spectrophotometer equipped with 7-positioned 
automatic sample changer. The absorbance curve at 234 nm was 
divided into three phases; lag time, propagation phase and 
decomposition phase. The lag time was measured as the interval 
between the intercept of tangent of the slope of the curve in 
the propagation phase with the base line and was expressed in 
minutes as defined by Hirano et al. [32].
Animal experiment 
Sprague-Dawley male rats weighing 150 ± 10 g obtained from 
Orient Bio Inc. (Kyunggido, Korea) were housed in a room with 
controlled temperature (20-22  degrees C), humidity (55-65%), 
and lighting (8 am-8 pm). After acclimatization for one week 
with a commercial non-purified purina chow, the rats were 
randomly divided into five groups of eight animals each and fed 
with high fat experimental diets [33,34]. Table 1 shows the details 
of five experimental diets according to AIN-93G [35] except for 
the modification in the carbohydrate contents. One group of rats 
(HF-control) was fed the high fat diet with no test material and 
two groups of rats were fed with the experimental diets to which 
1% of the 80% ethanol extract of defatted safflower seed (Saf), 
and the ginger extract (Gin) were added. Whilst, another two 
groups of rats were fed diets containing 1 and 2% of the ethanol 
extract of root bark of lycium (LCR1 and LCR2), respectively. Sung-Hee Cho et al. 415
Components
Diet group
HF-control Saf LCR1 LCR2 Gin
Casein 200 200 200 200 200
D , L - M e t h i o n i n e 3 3333
Cornstarch 171 161 161 151 161
Sucrose 370 370 370 370 370
C e l l u l o s e 5 0 5 05 05 05 0
S o y b e a n  o i l 2 0 2 02 02 02 0
Lard 130 130 130 130 130
Mineral mix
1) 42 42 42 42 42
Vitamin Mix
1) 12 12 12 12 12
C h o l i n e  b i t a r t r a t e 2 2222
t-Butylhydroquinone 0.04 0.04 0.04 0.04 0.04
Ethanol extract
Defatted safflower seed 10
Lycium
2) root bark 10
20
  Ginger 10
1) AIN-93G  formular
2) Lycium  chenese  Miller
Table 1. Composition of the experimental diets (g/kg)
(A)
(B)
Fig. 2. Effects of serotonin derivatives (CS, FS) from safflower seed and 
tyramine derivatives (CT, FT) from root bark of Lycium chenese Miller, ferulic 
acid (FA) and 10-gingerol on HMG-CoA reductase (A) and ACAT (B) activities. 
CS,  N-(p-cumaroyl)serotonin;  FS,  N-feruloylserotonin;  CT,  trans-N-coumaroyl-
tyramine; FT, trans-N-feruloyltyramine; FA, ferulic acid at the concentrations of 1.2 
mg/mL for HMG CoA reducatse and of 1 mg/mL for ACAT reactions. Values are 
means ± SD of three replicates and those with * and ** are significantly different 
from  none  at  P < 0.05  and  < 0.01,  respectively. 
The amount of the dried extracts added to the diets was 
determined in accordance with a previous study [36]. As 
described above, the amount of CT and FT, active components 
in the LCR extract was as low as about 10% of CS and FS 
in safflower seed or gingerols in ginger extracts. Therefore, a 
diet containing 2% of the LCR extract was prepared for the LCR2 
group in addition to LCR1. Inclusion of higher than 2% of the 
LCR extract in the experimental diet was considered as undesirable 
due to probable imbalances in the contents of macronutrients 
amongst the test diets. The rats were on experimental diets for 
4 weeks and body weight was measured during the feeding 
period, after which they were sacrificed to conduct biochemical 
analysis. This study was approved by Animal Use Committee 
of Catholic University of Daegu and maintained in accordance 
with the guidelines of Catholic University of Daegu on the care 
and use of laboratory animals. 
Total cholesterol, HDL-cholesterol, and triglyceride in serum 
obtained from the rats were quantified by using an enzyme kit 
(Asan Pharmaceutical, Seoul). Liver cholesterol and triglyceride 
were measured by using the same enzymatic kit and by the aid 
of a detergent, triton X-100, as described before [36]. Serum 
thiobarbituric acid reactive substances (TBARS), and index of 
lipid peroxidation, were measured according to a method 
developed by Yagi [37], which employed 1,1,3,3-tetraethoxy-
propane as a reference material. Glutamate oxaloacetate tran-
saminase (GOT) and glutamate pyruvate transaminase (GPT) 
activities, which are the indices of hepatic damage, and blood 
urea nitrogen (BUN), an index of protein metabolism disorder, 
were measured by using an enzyme kit (Asan Pharmaceutical, 
Seoul).
Statistical analysis 
Data were analyzed by student's t-test or analysis of variance 
(ANOVA), and differences were considered statistically significant 
at  P < 0.05 by Tukey’s test in the latter case. 
Results 
Inhibition of HMG CoA reductase and ACAT activities and LDL 
oxidation in in vitro investigation
The effects of CT and FT, LCR tyramines, on HMG CoA 
reductase and ACAT activities are presented in Fig. 2 (A, B) 
along with the effects of CS and FS, serotonin derivatives from 
safflower seed, and FA, and 10-gingerol. The concentrations of 
the test materials in the reaction mixtures of HMG CoA reductase 
and ACAT were 1.2 and 1 mg/mL, respectively. As shown in 
Fig. 1A, there was no change in the HMG CoA reductase activity 416 Hypocholesterolemic effect of  Lycii Cortex Radicis
Addition Conc.
(mg/mL)
Activity of HMG CoA 
reductase
(pmol NADPH/min/
mg protein)
Conc.
(mg/mL)
Activity of ACAT
(pmol oleylChol/min/
mg protein)
None 442.4 ± 27.9 892.6 ± 46.9 
FS
1)
1.2 225.8 ± 7.6**
  1.0 535.7 ± 9.4** 
0.6 221.4 ± 22.4* 0.5 615.4 ± 16.1** 
0.3 292.1 ± 38.5* 0.25 721.6 ± 18.5* 
FT
2)
1.2 193.4 ± 28.6* 1.0 456.5 ± 16.8** 
0.6 282.2 ± 28.1* 0.5 631.1 ± 23.4**
0.3 443.4 ± 40.3 0.25 752.3 ± 2.18** 
Simvastatin 
0.05 50.4 ± 4.6** 
0.005 161.1 ± 42.6**
1) N-feruloylserotonin, 
2) trans-N-feruloyltyramine 
Values are means ± SD of three replicates and those with * and ** are significantly 
different  from  none  at  P < 0.05  and  < 0.01,  respectively. 
Table 2. Effects of various concentration of N-feruloylserotonin and trans- 
N-feruloyltyramine on activities of HMG CoA reductase and ACAT 
Fig. 3. In vitro effects of serotonin derivatives (CS, FS) from safflower seed 
and tyramine derivatives (CT, FT) from root bark of Lycium chenese Miller, 
ferulic acid (FA) and 10-gingerol on LDL oxidation. CS, N-(p-cumaroyl)serotonin; 
FS,  N-feruloylserotonin;  CT,  trans-N-coumaroyltyramine;  FT,  trans-N-feruloyltyra-
mine; FA, ferulic acid at the concentration of 2.5 μg/mL. Values are means ± SD 
of three replicates and those with * and ** are significantly different from none at 
P < 0.05  and  < 0.01,  respectively. 
Group
1) Initial BW (g) Final BW (g) BW gain (g) Food intake (g) Food efficiency ratio
HF-control 217.0 ± 2.6
NS 417.8 ± 11.6
2)a 200.8 ± 10.5
a 647.8 ± 27.7
a 0.30 ± 0.01
a
Saf 212.0 ± 2.8 410.3 ± 13.6
a 198.3 ± 11.7
a 614.5 ± 20.3
a 0.32 ± 0.01
a
LCR1 205.8 ± 3.5 394.5 ± 11.6
ab 188.7 ± 9.6
a 601.3 ± 21.0
ab 0.31 ± 0.01
a
LCR2 200.2 ± 3.5 375.9 ± 8.1
b 175.8 ± 5.8
ab 551.8 ± 13.9
b 0.32 ± 0.01
a
Gin 212.0 ± 3.5 355.3 ± 13.5
b 143.3 ± 14.5
b 532.6 ± 24.6
b 0.27 ± 0.02
b
1) Groups  are  same  as  described  in  Table  1. 
2) V a l u e s  a r e  m e a n s±S D  f r o m  e i g h t  r a t s  a n d  t h o s e  w i t h  d if f e r e n t  a lphabet  letters  in  the  same  column  are  significantly  different  at  P < 0.05. 
NS,  not  significant
Table 3. Body weights, food intakes and food efficiency ratios of five experimental groups of rats fed with high fat diets for four weeks 
(296.5 ± 39.8 pmole NADPH/min/mg protein) with no test 
material (none), despite the addition of CS or CT. However, when 
FS and FT were added, the enzyme activity was decreased to 
186.4 ± 7.2 and 188.1 ± 10.2 pmole NADPH/min/mg protein, 
respectively, showing the activity inhibition rate as ~40%. On 
the hand, neither FA nor 10-gingerol had any inhibitory effect 
on HMG CoA reductase. Conversely, all the test materials used 
in this study, except FA had an inhibitory effect on ACAT 
activity (Fig. 1B). CS and FS decreased the ACAT activity by 
34-43% when compared to the activity (981.2 ± 56.4 pmol/min/ 
mg protein) in the absence of the test materials (none). Amongst 
all the LCR tyramines, FT was more effective in inhibiting 
ACAT activity (~50%) than CT. Among all the test materials, 
10-gingerol was the most effective in inhibiting ACAT activity 
by 80%. To examine the inhibitory actions of FS and FT at lower 
concentrations, the concentrations were reduced to 0.3 and 0.25 
mg/mL from 1.2 and 1 mg/mL in the reaction mixture of HMG 
CoA reductase and ACAT, respectively and the results are shown 
in Table 2. The inhibitory action of FS on HMG CoA reductase 
decreased from 49 to 34% and from 40 to 19% in the case of 
ACAT. Similarly, at FT’s concentration of 0.6 mg/mL, there was 
a decrease in HMG CoA reductase activity from 56 to 36% and 
from 49 to 16% in the case of ACAT. FS appeared to be more 
effective inhibitor of HMG CoA reductase activity than FT at 
low concentration, but both the compounds had the same efficacy 
in inhibiting ACAT activity. When FS and FT were compared 
with simvastatin, a well-known inhibitor of HMG CoA reductase, 
their efficacy was revealed to be 1/40
th of simvastatin.
The inhibition of  LDL oxidation by the test materials was 
shown as increase in lag time required for initiation of LDL 
oxidation (Fig. 3). LDL oxidation was significantly delayed by 
CT, FT, and 10-gingerol, while no significant change was 
observed in the presence of CS, FS and FA. 
Changes in body weight, food efficiency and fat pad weight in 
in vivo animal experiment
Initial and final body weights, body weight gains, food intakes, 
and food efficiency ratios of the five rat groups fed with 
experimental diets (Table 1) for 4 weeks are presented in Table 
3. The average initial body weight of rats was shown to be 209
± 10 g prior to the intake of experimental diets and there was 
no difference among the five groups, but there was a major 
difference in the final body weights of the groups. The final 
weights of the groups were in the descending order as HF-control, 
Saf, LCR1, LCR2 and Gin groups, the latter two of which had 
significantly lower body weights than HF-control and Saf group. 
This observation corresponded with the body weight gains and Sung-Hee Cho et al. 417
Region Group
1) Subscapular Epididymal Abdominal (g/100 g BW) Kidney Total fat weight
HF-control 0.11 ± 0.01
2)a 1.15 ± 0.09
a 1.58 ± 0.11
NS 0.45 ± 0.03
NS 3.29 ± 0.20
a
Saf 0.10 ± 0.01
a 0.94 ± 0.10
ab 1.41 ± 0.18 0.49 ± 0.04 2.94 ± 0.23
a
LCR1 0.12 ± 0.01
a 1.08 ± 0.11
a 1.58 ± 0.04 0.52 ± 0.05 3.29 ± 0.15
a
LCR2 0.10 ± 0.01
a 0.81 ± 0.06
b 1.35 ± 0.08 0.42 ± 0.03 2.68 ± 0.12
b
Gin 0.09 ± 0.01
b 0.79 ± 0.07
b 1.18 ± 0.13 0.38 ± 0.03 2.45 ± 0.22
b
1) Groups  are  same  as  described  in  Table  1. 
2) V a l u e s  a r e  m e a n s±S D  f r o m  e i g h t  r a t s  a n d  t h o s e  w i t h  d if f e r e n t  a lphabet  letters  in  the  same  column  are  significantly  different  at  P < 0.05. 
NS,  not  significant
Table 4. Fat pad weights at various regions in five experimental groups of rats fed with high fat diets for four weeks
Fig. 4. Effects on serum lipid levels in five experimental groups
1) of rats fed 
with high fat diets for four weeks. 
1) Groups are same as described in Table 1. 
Bars are means±SE from eight rats and those with different alphabet letters are 
at  P < 0.05. 
Fig. 5. Effects on liver lipid levels in five experimental groups
1) o f  r a t s  f e d  
with high fat diets for four weeks. 
1) Groups are same as described in Table 1. 
Bars are means±SE from eight rats and those with different alphabet letters are 
at  P < 0.05. 
Fig. 6. Effects on serum TBARS levels in five experimental groups
1) of rats 
fed with high fat diets for four weeks. 
1)  Groups are same as described in Table 
1. Bars are means ± SE from eight rats and those with different alphabet letters 
are  at  P < 0.05. 
food intakes. However, amongst the five experimental groups, 
food efficiency ratio was significantly lower only in Gin group. 
Table 4 shows weights of body fat pad in various parts of the 
animal body. Subscapular fat weight was lower in Gin group, 
whereas epididymal fat weights were significantly lower in LCR2 
and Gin groups than HF-control group. Total fat weights were 
also lower in LCR2 and Gin groups than HF-control, Saf and 
LCR1 groups.
Serum and liver levels of lipid
Fig. 4 shows serum levels of total cholesterol, HDL-cholesterol 
and triglyceride in the five groups of rats fed with the 
experimental diets. Total cholesterol level was significantly lower 
in Saf, LCR2 and Gin groups, and HDL cholesterol level was 
lower only in Gin group than in HF-control group, while there 
was no difference in the serum triglyceride levels among the 
five experimental groups, although it appeared to be lower in 
Gin group. The HDL-cholesterol/total cholesterol ratios (%) were 
in range from 63.3 ± 3.4 in HF-control group to 70.2 ± 2.9 in 
Saf group, but no significant difference was observed amongst 
the five groups.
Fig. 5 shows levels of liver cholesterol and triglyceride of 
the five experimental groups of rats. The level of liver cholesterol 
was significantly lower in LCR1 and LCR2 groups but not in 
Saf and Gin groups, when compared with HF-control. On the 
other hand, the level of liver triglyceride was lower in the four 
test groups than HF-control.
Serum TBARS, GOT, GPT and BUN
Serum levels of TBARS were significantly lower only in 
LCR2 group than in HF-control group, and the results are shown 
in Fig. 6. Serum GOT and GPT levels, hepatic damage indices, 
BUN, index of protein metabolism disorder, are presented in 
Table 5. When compared to HF-control group, no change in the 
values was observed in Saf, LCR1, LCR2, and Gin groups. 418 Hypocholesterolemic effect of  Lycii Cortex Radicis
Group
1) GOT (IU/L) GPT (IU/L) BUN (mg/dL)
HF-control 91.7 ± 4.5 37.0 ± 1.4 1.20 ± 0.41
Saf 82.9 ± 3.7 37.0 ± 1.0 0.87 ± 0.28
L C R 1 8 3 . 3±4 . 0 3 9 . 0±1 . 2 1 . 1 0±0 . 3 5
L C R 2 8 4 . 5±4 . 2 3 6 . 5±1 . 2 1 . 1 0±0 . 3 2
Gin 91.2 ± 3.6 36.1 ± 0.8 1.08 ± 0.34
1) Groups are same as described in Table 1. Values are means ± SE from eight 
rats. 
Table 5. Serum GOT, GPT and BUN levels in five experimental groups
Discussion
The present study revealed that the extract of Lycii Cortex 
Radicis (LCR), as well as safflower seed and ginger extracts, 
inhibited in vitro activities of HMG-CoA reductase and ACAT 
and also exhibited its effects on reduction of serum total 
cholesterol  in vivo. In particular, FT, a LCR phenolic amide, 
inhibited  in vitro enzyme activities as effectively as FS from 
safflower seed. Furthermore, it was interesting to note that the 
LCR extract containing the phenolic amides at much lower 
concentrations than serotonins in safflower seed extract, reduced 
in vivo serum cholesterol in a manner similar to safflower seed 
extract. On the basis of contents of CS, FS, CT, FT and gingerols 
of each extract, LCR1 and LCR2 diets contained about 0.07 g 
and 0.14 g of LCR tyramines per kg while Saf and Gin diets 
contained 0.84 g of serotonin derivatives and 0.63 g/kg of 
gingerols, respectively. Since FT, LCR tyramine did not have 
extensive effect on in vitro inhibition of HMG CoA reductase 
as FS at low concentrations (0.5 and 1.0 mg/mL), the presence 
of other substances in the bulk of the LCR extract might have 
contributed to hypocholesterolemic effect. Major substances 
present in the LCR extract are regarded to be carbohydrates, 
including minor amount of fiber and negligible amount of 
protein. The carbohydrates in the LCR extract are likely to be 
comprised of oligosaccharides, since plant roots such as burdock 
[38] and chicory [39] have been reported to contain inulin-type 
oligosaccharide. The oligosaccharides derived from plants had 
been reported to lower serum cholesterol levels [40,41] and 
dietary fructooligosaccharide were reported to reduce serum 
triglyceride levels in rats [42]. Therefore, the hypocholesterolemic 
effect shown by the LCR extract could partly be due to the 
presence of oligosaccharides and/or other substances, which 
remains to be investigated in the future; while the effect can 
be explained on the basis of direct inhibitory action of the FT 
on HMG CoA reductase to a certain degree. In the present study, 
it was also notable that the serum cholesterol level was reduced 
in vivo by ginger extract containing gingerols, including 
10-gingerol that was shown as an effective inhibitor of ACAT 
but not of HMG-CoA reductase. Only fewer reports are available 
on the simultaneous studies conducted both, in vitro and in vivo 
on inhibitory effects of materials from plants in conjunction with 
hyperlipidemia on enzymes, except for certain drugs with similar 
activity [2-4]. In our previous study [10], FS was reported to 
inhibit HMG CoA reductase activity but the effects of CS were 
not investigated. In this study, neither CS nor CT inhibited the 
enzyme activity. Therefore, it was inferred that feruloyl group 
was essential for the inhibition of the enzyme activity. But, the 
inhibitory action apparently seemed to require complex structures 
such as FS and FT, as ferulic acid alone did not inhibit the 
enzyme activity. Simvastatin (structure shown in Fig. 1) has been 
known to be a strong competitive inhibitor of HMG CoA 
reductase, because of the presence of 6-oxotetrahydro-2H- 
pyran-2-yl (marked part) group in the structure that binds to the 
active site of the enzyme. The action mechanisms of FS and 
FT in inhibiting HMG CoA reductase activity are yet to be 
resolved. Previous in vivo [7,8,43] and in vitro [5,9-13] studies 
have reported on inhibitions of HMG CoA reductase activity by 
various plant substances and extracts. However, in vitro 
inhibitory effect of FT from LCR on HMG CoA reductase was 
first reported in this study. Ferulic acid, which did not show 
an in vitro inhibitory effect on HMG CoA reductase, was reported 
to decrease the enzyme activity in vivo when it was offered to 
Apo-E deficient mice [44] or hyperlipidemic diabetic rats [45].
It was very significant to note that phenolic amides from LCR 
and serotonin derivatives from safflower seed showed an 
inhibitory effect on ACAT as well as HMG CoA reductase 
activity, which possibly helps to prevent hypercholesterolemia. 
Gingerols were more frequently reported to show anti-cancer 
effect [46,47] than hypolipidemic one, as it possess antioxidant 
and anti-inflammatory activities [48]. In this study, 10-gingerol 
was shown to have a high inhibitory effect on ACAT activity. 
Kim  et al. [14] have reported that LCR and ginger extracts 
inhibited in vitro ACAT activity by 8 and 30%, respectively when 
they examined the alcohol extracts from 303 plants. Based on 
the results, we inferred that FT and 10-gingerol are the main 
active components for the inhibitory action, as also reported by 
Kim et al. [14]. Decreased serum and liver cholesterol level by 
diet containing ginger extract seems to be associated with the 
potent inhibitory effect of gingerol on the ACAT activity. From 
the structural comparison between the test compounds used for 
in vitro enzyme assay in this study and pactimibe, a well-known 
ACAT activity inhibitor (Fig. 1), the nature of mechanisms 
involved in the ACAT inhibition by the compounds is not clear 
and further studies are needed to elucidate the underlying 
mechanisms. 
Lower body weight gains and less body fat amounts in LCR2 
and Gin when compared to other groups could be accounted due 
to less food intake, possibly because of bitter or repulsive taste 
of the diets. Although no difference in food efficiency was found 
between the control (HF-control) group and the two LCR groups, 
there was a decrease in the relative body fat amount in the LCR2 
group. It seems necessary to use extracts with less repulsive taste 
or to do isocaloric pair-fed study in future animal experiments. 
To the best of our knowledge, our report is the first one to 
demonstrate anti-oxidative effect of LCR tyramine, FT in terms 
of delayed LDL oxidation, although other studies have suggested 
the possibility of using LCR extract for the similar purpose Sung-Hee Cho et al. 419
[25,26]. The in vitro effect was well matched with reduction of 
serum TBARS in vivo in LCR2 groups. As described above, the 
tyramine contents of LCR2 diet were much less than the other 
active substances in Saf or Gin diet. To perceive more 
confirmative effects of the LCR tyramines, it is suggested to 
increase its content in the diet. This can be accomplished by 
using more purified extract or synthesized compounds [29]. An 
appropriate method could be chosen with due consideration about 
the economic aspect. Alternatively, various mixtures of LCR and 
ginger extracts could be used in diet to discover best efficacy 
and the strategy can be applicable for the production of functional 
foods.
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